# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate ...
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...
Jefferies analyst Jack Slevin assumes Oncology Institute (NASDAQ:TOI) with a Buy rating and announces Price Target of $2.5.
As of Jan. 8, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as ...
The Oncology Institute, Inc. (TOI) announced today that it has started operations of its first pharmacy in California after rec...